Type 1 diabetes and hyperglycemia

An analysis of the UK Clinical Practice Research Datalink indicates that elevated glycated hemoglobin levels are associated with an increased risk for infection among patients with diabetes.

Young patients with type 1 diabetes who have inadequate access to nutritional food are more likely to have poor glycemic control than those from food-secure households, researchers report.

Research shows that intervening to improve the diet quality of adolescents with type 1 diabetes does not exacerbate disordered eating behavior.

A bidirectional relationship between depression and severe dysglycemia exists among older people with type 1 diabetes, indicating a need for increased vigilance in this population.

Research suggests that a predictive low-glucose management system significantly reduces hypoglycemic events in children and adolescents with type 1 diabetes.

Results of the Onset 1 trial confirm that treatment with fast-acting insulin aspart provides improves glycemic control compared with conventional insulin aspart among adults with type 1 diabetes.

Research shows that switching to an insulin pump does not improve glycemic control in patients referred to an educational program after struggling to control their type 1 diabetes with multiple daily injections.

A study suggests that use of a virtual glucose management service can reduce hyper- and hypoglycemia among inpatients with diabetes by around a third.

Results of a preclinical study confirm that microvascular destabilization caused by diabetes exacerbates cardiac ischemic damage, but this damage may be partially combated with treatment to induce neovascularization.

Glucose variability rises with increasingly insulin-dependent forms of diabetes, report researchers.

Canagliflozin improves glycemic variability and treatment satisfaction in patients with type 1 diabetes using the sodium glucose cotransporter 2 inhibitor as an add-on to insulin, show findings from a randomized trial.

Accounting for the age of red blood cells strengthens the association between glycated haemoglobin and glucose levels, improving estimates of glycaemic control in patients with diabetes, a study shows.

A safety study finds that hyperglycaemia is the most common adverse event in patients with Type 1 diabetes using a closed-loop insulin delivery system on an outpatient basis.

The IN CONTROL trial demonstrates that continuous glucose monitoring improves glycaemic control in Type 1 diabetes patients who have hypoglycaemia unawareness.